IP Library Granted Patent US 10,744,115
Granted Patent B2
US 10,744,115 · App. 15/962,575 · Granted Aug 18, 2020

Compositions and methods for treating traumatic brain injury

Inventors: Alexander Baguisi (South Grafton, MA); Reinier Beeuwkes (Concord, MA); Ralph Casale (Westford, MA); David A. DeWahl, Jr. (Greenwich, CT); Steven A. Kates (Needham, MA); Alan S. Lader (Stoughton, MA)
Assignee: Ischemix LLC
A61K31/385A61K31/4178A61K31/661A61K31/662A61K45/06A61P25/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,744,115
App. No.
15/962,575
Granted
Aug 18, 2020
Kind
B2
Abstract

The present invention relates, in certain embodiments, to methods for preventing and/or treating neurodegenerative damage (e.g., secondary cascade of neurodegenerative damage) and improving functional outcomes (e.g., outcomes associated with cognitive, behavior and sensorimotor function) caused by traumatic brain injury using neuroprotective lipoyl compounds. The present invention also provides, in various embodiments, compositions for use in treating and/or preventing TBI in a subject in need thereof, compounds for use in the manufacture of a medicament for treating and/or preventing TBI in a subject in need thereof, and methods of preparing a pharmaceutical composition for treating and/or preventing secondary brain damage caused by TBI.

Claims (10)

1. A method for treating traumatic brain injury in a subject in need thereof, comprising administering to the subject an effective amount of a compound of the following structural formula:

or a pharmaceutically acceptable salt or prodrug thereof.

2. The method of claim 1 , wherein the method is a method for treating neurodegenerative damage caused by traumatic brain injury.

3. The method of claim 2 , wherein the neurodegenerative damage affects the hippocampus region of the brain.

4. The method of claim 3 , wherein the neurodegenerative damage to the hippocampus region of the brain affects cognitive function associated with learning and memory.

5. The method of claim 2 , wherein the neurodegenerative damage affects sensorimotor function.

6. The method of claim 2 , wherein the neurodegenerative damage is associated with a focal or diffused traumatic brain injury.

7. The method of claim 2 , wherein the neurodegenerative damage is secondary damage at a site other than the site of the primary lesion.

8. The method of claim 1 , wherein the method is a method for improving a functional outcome following traumatic brain injury.

9. The method of claim 8 , wherein the functional outcome is associated with cognitive, behavior or sensorimotor function in the subject.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2019
From: BAGUISI, ALEXANDER; BEEUWKES, REINIER; CASALE, RALPH; DEWAHL, DAVID A.; KATES, STEVEN A.; LADER, ALAN S.
To: ISCHEMIX LLC
Reel/Frame 050184/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2018
From: CASALE, RALPH; KATES, STEVEN A.; BAGUISI, ALEXANDER; DEWAHL, DAVID; BEEUWKES, REINIER; LADER, ALAN S.
To: ISCHEMIX LLC
Reel/Frame 046471/0064 →
Continuity (2)
Provisional Application 62489735 · Apr 25, 2017
Related Publication 20180303796A1 · Oct 25, 2018